Chester County News and Community Website
WAYNE, PA — Ecovyst Inc. (NYSE: ECVT) raised its 2026 earnings and sales forecasts after second-quarter adjusted EBITDA climbed 27%, incorporating the expected contribution from its newly acquired Calabrian sulfur …
Ecovyst Raises 2026 Outlook After Calabrian Acquisition Read More
BERWYN, PA — AMETEK Inc. (NYSE: AME) raised its full-year earnings outlook after second-quarter adjusted profit climbed 17% and orders surged 28%, signaling continued demand across semiconductor, aerospace, defense, medical …
AMETEK Raises 2026 Outlook After Earnings Climb 17% Read More
WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) reported a $13.2 million second-quarter loss as total revenue fell sharply from a year earlier despite record demand and higher U.S. …
Verrica Revenue Falls Despite Record YCANTH Demand Read More
MALVERN, PA — Ocugen Inc. (NASDAQ: OCGN) extended its expected cash runway into 2028 with a $130 million convertible debt financing as the biotechnology company moves one retinal gene therapy …
Ocugen Raises $130 Million as Gene Therapy Trials Advance Read More
WAYNE, PA — Aclaris Therapeutics Inc. (NASDAQ: ACRS) raised $40.2 million through an at-the-market stock sale after the second quarter, extending its expected cash runway through the end of 2028 …
Aclaris Raises Capital as Drug Pipeline Spending Accelerates Read More
MALVERN, PA — Vishay Intertechnology Inc. (NYSE: VSH) reported higher sequential revenue in the second quarter and projected another increase for the current period as orders outpaced shipments across its …
Vishay Revenue Climbs as Orders Point to Further Growth Read More
CHESTERBROOK, PA — Vishay Precision Group, Inc. (NYSE: VPG) reported stronger second-quarter sales and $95.5 million in orders, but unfavorable currency movements and delayed shipments pushed the precision-measurement company to …
VPG Orders Rise as Currency Pressure Pushes Results to Loss Read More
WAYNE, PA — Palvella Therapeutics, Inc. (Nasdaq: PVLA) began its rolling U.S. application for QTORIN rapamycin during the second quarter as higher clinical, manufacturing and regulatory spending more than doubled …
Palvella Advances FDA Filing as Drug Spending Lifts Loss Read More
EXTON, PA — Innovative Aerosystems (Nasdaq: ISSC) will report fiscal third-quarter 2026 results before markets open Aug. 13, followed by a 10 a.m. ET conference call covering financial performance, recent …
Innovative Aerosystems Sets Aug. 13 Earnings Call Read More
MALVERN, PA — CubeSmart (NYSE: CUBE) raised the midpoint of its 2026 earnings and operating guidance after improving occupancy and rental pricing supported second-quarter revenue growth, though higher property expenses …
CubeSmart Raises 2026 Outlook as Storage Demand Improves Read More